AVAH · NASDAQ
Aveanna Healthcare Holdings (AVAH) Stock Price & Fundamentals
Aveanna Healthcare Holdings (AVAH) closed at $1,237.32 on Oct 9, 2026, up 0.74% from the previous close of $1,228.24.
Share price, past year
1Y +24.91%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,237.32 |
| Sep 30, 2026 | $1,170.54 |
| Aug 31, 2026 | $1,201.65 |
| Jul 31, 2026 | $1,281.51 |
| Jun 30, 2026 | $1,203.84 |
| May 29, 2026 | $1,196.28 |
| Apr 30, 2026 | $1,036.03 |
| Mar 31, 2026 | $1,004.70 |
| Feb 27, 2026 | $949.29 |
| Jan 30, 2026 | $1,030.43 |
| Dec 31, 2025 | $983.98 |
| Nov 28, 2025 | $993.72 |
| Oct 31, 2025 | $961.15 |
Key statistics
- Market cap
- $269.92B
- P/E (TTM)
- 982.0
- EPS (TTM)
- $1.26
- Revenue (TTM)
- $2.60B
- Net income (TTM)
- $274.76M
- Shares outstanding
- 218.2M
- Dividend yield
- —
- 52-week range
- $948.34 – $1,281.51
Aveanna Healthcare Holdings's market cap is $269.92B, based on a share price of $1,237.32 and 218.2M shares outstanding as of Jul 4, 2026.
Financials
Aveanna Healthcare Holdings reported revenue of $2.43B for fiscal 2026.
Aveanna Healthcare Holdings earned net income of $225.03M in fiscal 2026, a net margin of 9.2%.
Fiscal 2026 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jan 3, 2026 | $2.43B | +20.2% | $225.03M | 9.3% | $1.05 | — |
| FY2024ended Dec 28, 2024 | $2.02B | +6.8% | −$10.93M | −0.5% | −$0.06 | — |
| FY2023ended Dec 30, 2023 | $1.90B | +6.0% | −$134.52M | −7.1% | −$0.71 | — |
| FY2022ended Dec 31, 2022 | $1.79B | +6.5% | −$662.03M | −37.0% | −$3.57 | −$27.30M |
| FY2022ended Jan 1, 2022 | $1.68B | +12.3% | −$662.03M | −39.4% | −$3.57 | −$27.30M |
| FY2021ended Jan 2, 2021 | $1.50B | +8.0% | −$57.05M | −3.8% | −$0.40 | $101.38M |
| FY2019ended Dec 28, 2019 | $1.38B | — | −$76.52M | −5.5% | — | −$25.35M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2027ended Jul 4, 2026 | $670.48M | $40.29M | $0.18 |
| Q1 FY2027ended Apr 4, 2026 | $647.92M | $41.65M | $0.19 |
| Q4 FY2026ended Jan 3, 2026 | $662.48M | $178.75M | $0.83 |
| Q3 FY2026ended Sep 27, 2025 | $621.94M | $14.06M | $0.06 |
| Q2 FY2026ended Jun 28, 2025 | $589.55M | $27.03M | $0.13 |
| Q1 FY2026ended Mar 29, 2025 | $559.22M | $5.19M | $0.03 |
| Q4 FY2024ended Dec 28, 2024 | $519.87M | $29.18M | — |
| Q3 FY2024ended Sep 28, 2024 | $509.02M | −$42.84M | −$0.22 |
Company profile
- Name
- Aveanna Healthcare Holdings, Inc.
- Ticker
- AVAH
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Home Health Care Services
- Headquarters
- 400 Interstate North Parkway, Ste 1700, Atlanta, GA 30339
- Incorporated in
- DE
- Fiscal year ends
- January
- SEC CIK
- 0001832332
Recent SEC filings
- Oct 2, 2026
- Aug 24, 2026
- Aug 13, 2026
- Aug 13, 2026
- Aug 13, 2026
- Aug 7, 2026
- Jun 2, 2026
- May 29, 2026
Frequently asked questions
What is Aveanna Healthcare Holdings's stock price?
Aveanna Healthcare Holdings (AVAH) closed at $1,237.32 on Oct 9, 2026, up 0.74% from the previous close of $1,228.24.
What is Aveanna Healthcare Holdings's market cap?
Aveanna Healthcare Holdings's market cap is $269.92B, based on a share price of $1,237.32 and 218.2M shares outstanding as of Jul 4, 2026.
How much revenue does Aveanna Healthcare Holdings make?
Aveanna Healthcare Holdings reported revenue of $2.43B for fiscal 2026.
What is AVAH's P/E ratio?
Aveanna Healthcare Holdings's price-to-earnings ratio is 982.0, based on trailing twelve-month diluted EPS of $1.26.
Does Aveanna Healthcare Holdings pay a dividend?
Aveanna Healthcare Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Aveanna Healthcare Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures